Bolt Biotherapeutics, Inc. (BOLT)
6.24
-0.19
(-2.95%)
USD |
NASDAQ |
Nov 10, 10:16
Bolt Biotherapeutics Cash and Short Term Investments (Quarterly) : 17.80M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 17.80M |
| March 31, 2026 | 23.09M |
| December 31, 2025 | 27.70M |
| September 30, 2025 | 32.69M |
| June 30, 2025 | 35.55M |
| March 31, 2025 | 39.62M |
| December 31, 2024 | 48.11M |
| September 30, 2024 | 54.59M |
| June 30, 2024 | 73.70M |
| March 31, 2024 | 91.35M |
| December 31, 2023 | 102.19M |
| September 30, 2023 | 119.72M |
| June 30, 2023 | 125.87M |
| March 31, 2023 | 126.38M |
| Date | Value |
|---|---|
| December 31, 2022 | 168.89M |
| September 30, 2022 | 171.13M |
| June 30, 2022 | 176.34M |
| March 31, 2022 | 190.90M |
| December 31, 2021 | 186.22M |
| September 30, 2021 | 212.89M |
| June 30, 2021 | 244.99M |
| March 31, 2021 | 266.67M |
| December 31, 2020 | 22.84M |
| September 30, 2020 | 37.75M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 34.83M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Caribou Biosciences, Inc. | 94.80M |
| Arrowhead Pharmaceuticals, Inc. | 1.602B |
| Oncolytics Biotech, Inc. | 4.115M |
| Sangamo Therapeutics, Inc. | 27.59M |
| Sarepta Therapeutics, Inc. | 878.78M |